Wird geladen...
Novel Experimental Agents for the Treatment of Hypercholesterolemia
Atherosclerotic cardiovascular diseases (ASCVD) are still the leading cause of morbidity and mortality in most developed countries and even more in developing countries. Dyslipidemia is a well known main risk factor for ASCVD. Lipid-lowering treatment, particularly lowering LDL-cholesterol (LDL-C),...
Gespeichert in:
| Veröffentlicht in: | J Exp Pharmacol |
|---|---|
| Hauptverfasser: | , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Dove
2021
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7887150/ https://ncbi.nlm.nih.gov/pubmed/33603500 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/JEP.S267376 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|